Altered glycosylation of MUC1 in tumor microenvironment (WP4480)

Homo sapiens

Open in new tab Open in NDEx Open in Newt (SBGN)
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
Altered MUC1 glycosylation extends to its role as a promoter of chronic inflammatory conditions that lead to malignant transformation and cancer progression.

Authors

Laurent Winckers , Kristina Hanspers , Eric Weitz , and Egon Willighagen

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

CPTAC PancCanNet

Annotations

Pathway Ontology

disease pathway cancer pathway

Cell Type Ontology

T cell dendritic cell macrophage

Disease Ontology

cancer

Participants
Query Drugst.One

Label Type Compact URI Comment
IkKB GeneProduct ncbigene:8517
TNF GeneProduct ncbigene:7124
IkKA GeneProduct ncbigene:1147
IkKG GeneProduct ncbigene:3551
IkBA GeneProduct ncbigene:4792
RELA GeneProduct ncbigene:5970
IL6 GeneProduct ncbigene:3569
MUC1 GeneProduct ncbigene:4582
NFKB1 GeneProduct ncbigene:4790

References

  1. Introduction to NF-kappaB: players, pathways, perspectives. Gilmore TD. Oncogene. 2006 Oct 30;25(51):6680–4. PubMed Europe PMC Scholia
  2. Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis. Cascio S, Finn OJ. Biomolecules. 2016 Oct 13;6(4):39. PubMed Europe PMC Scholia